Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE4.5650
- TODAY'S CHANGE (%)0.0250 (0.5507%)
- Bid / Lots4.5500/ 8
- Ask / Lots4.5800/ 5
- Open / Previous Close4.5100 / 4.5400
- Day Range
- 52 Week Range
- Volume73,680
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 5914 | 4.62 |
| 09:36 ET | 3053 | 4.45 |
| 09:38 ET | 600 | 4.48 |
| 09:39 ET | 100 | 4.49 |
| 09:41 ET | 500 | 4.5 |
| 09:43 ET | 1075 | 4.525 |
| 09:50 ET | 500 | 4.55 |
| 09:52 ET | 5000 | 4.5416 |
| 09:57 ET | 200 | 4.54 |
| 09:59 ET | 100 | 4.57 |
| 10:01 ET | 2837 | 4.575 |
| 10:03 ET | 5214 | 4.6 |
| 10:06 ET | 800 | 4.56 |
| 10:08 ET | 690 | 4.55 |
| 10:12 ET | 5811 | 4.515 |
| 10:14 ET | 100 | 4.505 |
| 10:15 ET | 1669 | 4.55 |
| 10:24 ET | 300 | 4.5722 |
| 10:28 ET | 300 | 4.6 |
| 10:32 ET | 1003 | 4.54 |
| 10:33 ET | 1700 | 4.53 |
| 10:35 ET | 680 | 4.5123 |
| 10:44 ET | 100 | 4.501 |
| 10:50 ET | 105 | 4.52 |
| 10:51 ET | 100 | 4.5329 |
| 10:55 ET | 105 | 4.52 |
| 10:57 ET | 391 | 4.52 |
| 11:00 ET | 100 | 4.52 |
| 11:08 ET | 200 | 4.52 |
| 11:09 ET | 3720 | 4.51 |
| 11:11 ET | 1523 | 4.5 |
| 11:13 ET | 3934 | 4.51 |
| 11:15 ET | 1650 | 4.52 |
| 11:18 ET | 150 | 4.5101 |
| 11:26 ET | 973 | 4.55 |
| 11:27 ET | 350 | 4.54 |
| 11:31 ET | 100 | 4.53 |
| 11:42 ET | 100 | 4.51 |
| 11:44 ET | 524 | 4.53 |
| 11:45 ET | 898 | 4.55 |
| 11:51 ET | 3500 | 4.58 |
| 11:54 ET | 100 | 4.59 |
| 11:58 ET | 334 | 4.59 |
| 12:02 ET | 1400 | 4.58 |
| 12:12 ET | 100 | 4.57 |
| 12:14 ET | 600 | 4.56 |
| 12:16 ET | 100 | 4.57 |
| 12:25 ET | 1123 | 4.565 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 356.5M | -2.7x | --- |
Erasca Inc | 353.6M | -2.4x | --- |
Skye Bioscience Inc | 364.8M | -2.3x | --- |
Fibrobiologics Inc | 345.2M | -11.0x | --- |
Aura Biosciences Inc | 371.3M | -3.8x | --- |
Q32 Bio Inc | 346.4M | -0.8x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Secretary
- Faraz Ali
- Chief Financial and Business Officer
- Leone Patterson
- Chief Scientific Officer
- Timothy Hoey
- Chief Medical Officer
- Whittemore Tingley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $356.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.68 |
Book Value | $2.04 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
